![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Data indicates that SON-080 was well-tolerated at both doses, with no evidence of a pro-inflammatory cytokine responsePain and quality of life survey results suggest the potential for rapid...
PRINCETON, N.J., June 20, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the โCompanyโ or โSonnetโ), a clinical-stage company developing targeted immunotherapeutic...
Sonnet discovered and characterized a modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with...
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 2611 | 0.0001 | CS |
4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 216307 | 0.0001 | CS |
12 | -0.0002 | -66.6666666667 | 0.0003 | 0.0005 | 0.0001 | 1371662 | 0.0003215 | CS |
26 | -0.00065 | -86.6666666667 | 0.00075 | 0.0014 | 0.0001 | 8863730 | 0.00065332 | CS |
52 | -0.0008 | -88.8888888889 | 0.0009 | 0.0014 | 0.0001 | 8471266 | 0.00068631 | CS |
156 | -0.0119 | -99.1666666667 | 0.012 | 0.0213 | 0.0001 | 6381416 | 0.00330036 | CS |
260 | -0.0013 | -92.8571428571 | 0.0014 | 0.0213 | 0.0001 | 7427779 | 0.00385727 | CS |
Symbol | Price | Vol. |
---|---|---|
GMPRGourmet Provisions International Corporation (PK) | $ 0.0001 (-33.33%) | 384.39M |
SIRCSolar Integrated Roofing Corporation (PK) | $ 0.0001 (0.00%) | 78.88M |
HIRUHiru Corporation (PK) | $ 0.0029 (-29.27%) | 76.76M |
KGKGKona Gold Beverage Inc (PK) | $ 0.00065 (8.33%) | 69.18M |
NBRINorth Bay Resources Inc (PK) | $ 0.0004 (-20.00%) | 65.31M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions